The Venture Codex Logo

The Venture Codex

Brace Pharma Capital

387 Technology Cir NW Suite 225, Atlanta, GA, 30313, United States

Overview

Strategic investment in innovative therapies for unmet medical needs.

Founded

2013

Deals ยท 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series B
Series C

Geographic focus

United Kingdom
United States

Sector focus

Biotechnology

Investment portfolio

21rounds
NAMEDATESIZE
F2G
Sep 2024Participated
$100 MOther Equity
Antiva Biosciences
Nov 2021Participated
$31 MSeries D
Turnstone Biologics
Jul 2021Participated
$80 MSeries D
ReViral
Aug 2020Participated
$44 MSeries C
F2G
Aug 2020Participated
$61 MOther Equity
HotSpot Therapeutics
May 2020Participated
$65 MSeries B
Avidity Biosciences
Nov 2019Participated
$100 MSeries C
ReViral
Aug 2018Participated
$55 MSeries B
Antiva Biosciences
Jul 2018Participated
$15 MSeries C
Precision BioSciences
Jun 2018Participated
$110 MSeries B
Avrobio
Feb 2018Participated
$60 MSeries B
Antiva Biosciences
Mar 2017Led
$22 MSeries C
F2G
Sep 2024Participated
$100 MOther Equity
Antiva Biosciences
Nov 2021Participated
$31 MSeries D
Turnstone Biologics
Jul 2021Participated
$80 MSeries D
ReViral
Aug 2020Participated
$44 MSeries C
F2G
Aug 2020Participated
$61 MOther Equity
HotSpot Therapeutics
May 2020Participated
$65 MSeries B
Avidity Biosciences
Nov 2019Participated
$100 MSeries C
ReViral
Aug 2018Participated
$55 MSeries B
Antiva Biosciences
Jul 2018Participated
$15 MSeries C
Precision BioSciences
Jun 2018Participated
$110 MSeries B
Avrobio
Feb 2018Participated
$60 MSeries B
Antiva Biosciences
Mar 2017Led
$22 MSeries C
21
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Brace Pharma Capital: 21 funding rounds are recorded in the selected participation categories.All available history.
Brace Pharma Capital: 21 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B27
Series C+26
Other Equity03

Monthly Deal Activity

Brace Pharma Capital: 21 deals are recorded across 149 months.All available history.
Brace Pharma Capital: 21 deals are recorded across 149 months. All available history
MonthDeals
Jun '141
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '141
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '151
Jul '150
Aug '150
Sep '150
Oct '150
Nov '152
Dec '151
Jan '161
Feb '160
Mar '160
Apr '160
May '160
Jun '161
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '171
Feb '170
Mar '171
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '181
Mar '180
Apr '180
May '180
Jun '181
Jul '181
Aug '181
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '201
Jun '200
Jul '200
Aug '202
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '211
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Brace Pharma Capital: Health & Life Sciences is the largest displayed sector by deal count (21 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Brace Pharma Capital: Health & Life Sciences is the largest displayed sector by deal count (21 deals). All available history
SectorDeals
Health & Life Sciences21
Professional Services1
Developer Tools1

Deal Size Distribution

Brace Pharma Capital: 21 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Brace Pharma Capital: 21 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M5
$25M-$50M4
$50M-$100M8
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Brace Pharma Capital: United States has the largest recorded deal count among the displayed regions (15 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Brace Pharma Capital: United States has the largest recorded deal count among the displayed regions (15 deals). All available history
RegionDeals
United States15
Europe5
Canada1
Brace Pharma Capital: 20 co-investors are shown, with Atlas Venture sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Brace Pharma Capital: 20 co-investors are shown, with Atlas Venture sharing 5 recorded deals. All available history
Co-investorShared deals
Atlas Venture5
Novo Holdings5
Alexandria Venture Investments4
F-Prime Capital4
Osage University Partners4
Perceptive Advisors4
Advent Life Sciences3
Canaan Partners3
Cormorant Asset Management3
Lumira Ventures3
New Leaf Venture Partners3
OrbiMed3
Sectoral Asset Management3
Sofinnova Ventures3
Aisling Capital2
Alethea Capital2
Amgen Ventures2
Andera Partners2
Cowen Healthcare Investments2
EcoR1 Capital2

Investment Strategy

Brace Pharma Capital: Led accounts for 19% and participating for 81% of round participation.All available history.
Brace Pharma Capital: Led accounts for 19% and participating for 81% of round participation. All available history
CategoryDeals (count)Share (%)
Led419%
Participating1781%
Brace Pharma Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Brace Pharma Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead4100%
Co-led00%

Team

Vinzenz Ploerer

Founder, President & CEO